Background: Eosinophils in the nasal mucosa are an elemental feature of allergic
| INTRODUCTION
Eosinophils are tissue leucocytes that have complex and multifactorial roles in promoting health and disease. 1, 2 While relatively few eosinophils are found in the respiratory tract at homeostasis, 3 eosinophils can be mobilized in large numbers in response to allergic stimuli, notably via the coordinate actions of Th2 cytokines and chemoattractants. 4 Until recently, eosinophils recruited to tissues were perceived as uniformly destructive and cytotoxic. However, current research has led to a new appreciation of eosinophils as having more sophisticated, immunomodulatory properties, and the capacity to promote tissue regeneration and repair. 5 Several lines of evidence have suggested a role for eosinophils in modulating respiratory virus infection. 6, 7 Among these, severe infection with respiratory syncytial virus (RSV), the most common infection among infants and children world-wide, is accompanied by eosinophil recruitment to the lower airways. 8 While epidemiologic studies have defined a relationship between severe RSV infection and recurrent wheezing during childhood, the numerous factors contributing to this observation remain to be fully elucidated. 9 Likewise, infection with rhinovirus (RV) has been identified as a prominent factor contributing to asthma exacerbations. 10 Beale et al 11 have
pointed to RV-mediated induction of IL-25, a cytokine with the capacity to augment eosinophilic inflammation, as a critical element promoting this response, although Hong et al 12 suggest that RVinduced exacerbations are mediated primarily by neutrophils.
Particularly intriguing are the reports that consider eosinophils as mediators of antiviral host defence. For example, Adamko et al 13 reported that ovalbumin-sensitized guinea-pigs displayed IL5-and eosinophil-dependent antiviral activity against mouse parainfluenza virus. Phipps et al 14 found that RSV virions were cleared more rapidly from the lungs of eosinophil-enriched IL5tg mice, and that this response was dependent on MyD88-signalling. Percopo et al 15 reported that eosinophils in lung tissue were activated by and underwent degranulation in response to acute infection with pneumonia virus of mice (PVM), and likewise that eosinophils provided crucial protection against the lethal sequelae of this infection. Most recently, Samarasinghe et al 16 found that eosinophils themselves were susceptible to infection with influenza virus (H1N1), and that adoptive transfer of eosinophils from the lungs of allergic mice into the lungs of influenza virus-infected mice resulted in a significant reduction in lung virus titre.
All the aforementioned studies focused on eosinophils and viruses interacting with one another in the lower airways. In this study, our intent was to examine eosinophil-mediated responses to virus infection in the upper airways. The nasal epithelium is a critical interface and an important portal of entry for influenza virus. 17, 18 To explore the interactions between eosinophils and virus infection in the upper airways, we subjected mice to a regimen of repetitive inhalation of strict intranasal volumes (as defined experimentally by Southam et al 19 ) of a filtrate of the aeroallergen, Alternaria alternata. Fungal allergens have been featured previously in mouse models of allergic rhinitis 20, 21 ; this strategy, which utilizes intranasal challenges only without systemic sensitization, is based directly on the allergic rhinitis model developed by McCusker et al 22 who documented eosinophil recruitment to the nasal mucosae of BALB/c mice, also in response to strict intranasal inoculation with increasing concentrations of ovalbumin. We have featured A. alternata in our studies, as it is a prominent environmental allergen, prevalent in soil and as well as within homes with abundant moisture or insect infestation. 23 From a human clinical perspective, repetitive exposure to A. alternata is among the major risk factors for developing allergic manifestations, including rhinitis. 24 Here, we report that repetitive intranasal stimulation with A. alternata results in eosinophil recruitment to the upper airways and, surprisingly, unanticipated morbidity and mortality in response to a minimal inoculum of influenza virus, the latter associated with neutrophil recruitment and local overproduction of pro-inflammatory cytokines, including IL-6 and CCL-2. Unexpectedly, and in contrast to earlier findings focused on eosinophils in the lower airways, [13] [14] [15] [16] eosinophils in the nasal passages had no measurable impact against lethal respiratory virus infection.
| METHODS

| Mice
Wild-type C57BL/6 and BALB/c mice (6-10 weeks old) were from Charles River Laboratories, Frederick, MD. Rag1 
| Allergen challenge
Mice under isoflurane anaesthesia were inoculated intranasally with a reconstituted filtrate of A. alternata (Greer Allergy Immunotherapy;
10 mg/mL in Hanks' buffered saline solution, 50 lg/mouse delivered in a strict intranasal dose of 2.5 lL per nare 19 ) on days 0, 2, 4 (week 1), 7, 9, 11 (week 2), and 14, 16, and 18 (week 3) or diluent alone at each time-point as shown in Figure 1A . In some experiments, mice were inoculated as above with A. alternata that was heated to 95°C in a thermocycler for 10 minutes and stored at À80°C prior to inoculation. At time-points indicated (days 7, 14, or 21, at week 1, 2, and 3, respectively), mice were killed and subjected to nasal wash with a total per mouse of 0.8 mL phosphate-buffered saline (PBS) with 0.1% bovine serum albumin (BSA; 26 ) without protease-digestion of the submucosa. Typical recovery was 0.5 to 0.6 mL per mouse.
Given the limited volume of nasal wash fluid obtained, all assays
were not performed on each sample. 
| Protease activity
| Influenza virus infection
Influenza A/HK/1/68 (gift from J. Keicher, Symmune Therapeutics, Raleigh, NC) was provided to us as egg-passaged stock, and was passaged 3 times in wild-type-specific pathogen-free mice in our highbarrier facility prior to utilization in in vivo experiments. This was performed to avoid inoculating foreign (egg) antigens during the experimental trials. Influenza virus stocks were maintained at À80°C F I G U R E 1 Repetitive administration of the aeroallergen, Alternaria alternata, to the nasal passages results in eosinophilic inflammation. A, Strategy for repetitive challenge with A. alternata antigens (filtrate; 10 mg/mL) administered at strict intranasal volumes (2.5 lL per nare 19 ) over a 3 (3)-week period as described in the Methods Section. B, Eosinophils (percent of total leucocytes) are prominent in nasal wash fluid of wild-type but not eosinophil-deficient DdblGATA mice or lymphocyte-deficient Rag1 À/À mice in response to A. alternata administered as in Figure 1A ; inset, eosinophils from nasal wash fluid of wild-type mice stained with modified Giemsa. C, Eosinophils (total in 0.6 mL nasal wash fluid) at weeks 0, 1, 2 and 3 as in Figure 1A . D, RNase activity, a measure of eosinophil degranulation, detected in nasal wash fluid of wildtype, but not DdblGATA or Rag1 À/À mice; dotted line, limit of background activity. E, IgA detected in nasal wash fluid of wild-type and DdblGATA mice, but not Rag1 À/À mice; n = 3-8 mice per time-point, ***P < .005, **P < .01, *P < .05, ns, no statistical significance, 1-way ANOVA or Mann-Whitney U-test as clarified lung homogenates in phosphate-buffered saline (PBS) at 3 9 10 7 TCID 50 units/mL. In experimental studies, allergen or diluent-challenged mice were inoculated under isoflurane anaesthesia with influenza virus at varying dilutions (30, 150, or 500 TCID 50 units/mouse). Virus was administered intranasally in a total volume of 2.5 lL per nare (5 lL per mouse) and evaluated by serial weights and survival. Using this volume of inoculum, we are unable to obtain reliable MLD50 data in na€ ıve C57BL/6 recipient mice, even using 10-times more virus (ie 5000 TCID 50 units/mouse). In other experiments, mice were killed on day 6 after virus inoculation for evaluations as below.
| Evaluation of cells and cytokines in nasal wash fluid
Cytospins were prepared (100 lL per slide) and stained with modi- 
| Histology
The heads of A. alternata-challenged mice were excised and fixed in cold 10% buffered formalin. After fixation, the tissue was decalcified, paraffin embedded, and sectioned from anterior to posterior, and stained with haematoxylin and eosin by Histoserv, Inc. (Germantown, MD). Reference points for sections were as described by Mery et al. 27 The scale bars in the images were estimated based on the known diameter of a mouse eosinophil at 10 lm. 28 
| RNase assay
Enzymatic activity in 50 lL samples of cell-free nasal wash fluid was determined as previously described. 29 
| Nasal wash IgA
Total IgA in cell-free nasal wash samples was determined by ELISA as per manufacturer's instructions (Abcam).
| Tissue Culture Infectious Dose (TCID) 50 assay
This assay was performed as previously described to titrate pneumoviruses 30 with some specific changes as follows: briefly, MadinDarby Canine Kidney (MDCK) cells were seeded at 0.8 9 10 5 per well in 250 lL growth medium (DMEM high glucose with 7.5% fetal bovine serum (FBS), 4 mmol/L glutamine and penicillin/stretptomycin) in a 48-well plates. At t = 24 hours, wells were rinsed with serum-free medium (as above, without FBS) and serial dilutions of virus were added in infection medium (growth medium without FBS with 1 lg/mL TPCK trypsin). Virus-free control wells are included.
After 2 hours of virus adsorption at 34°C in CO 2 incubator, viruscontaining medium was removed and fresh infection medium was added. Plates were incubated at 34°C in CO 2 incubator and cytopathic effect (CPE) is monitored for 1 week. TCID 50 titre per mL of virus stock per mL of bronchoalveolar lavage fluid or per mg lung tissue homogenate (the latter determined by BCA assay (Pierce)) were calculated by the method of Reed and Muench as described.
| Virus titration by qPCR
Virus was evaluated in nasal wash fluid and in whole lung tissue using a qPCR assay that targets the Influenza A/HK/1/68 matrix (M1) protein (Genbank Accession no. AF348188) via a method analogous to that described by our laboratory for evaluating pneumonia virus of mice (PVM; 31, 32 ). Briefly, RNA was prepared from mouse This value is generated using commercially available mouse GAPDH primer-probes (Applied Biosystems catalog no. 4308313); values obtained are interpolated to a standard curve generated using a mouse GAPDH plasmid in pCMV pSport 6 (American Type Culture Collection cat no. 10539385), also as previously described. 3.2 | Eotaxin-1 (CCL-11) promotes eosinophil recruitment to nasal passages CCL-11 is a major eosinophil chemoattractant and typically pairs with IL-5 to activate and recruit eosinophils in response to allergic provocation. 35 Repetitive stimulation with a filtrate of A. alternata results in elevated levels of IL-5 ( Figure 2A ) and IL-13 ( Figure 2B ) in nasal wash fluid. Eotaxin-1 was detected at 39 AE 10 and 70 AE 12 pg/mL at weeks 2 and 3, respectively, at levels 13-fold and 24-fold over baseline ( Figure 2C ). Administration of A. alternata to eotaxin-1 gene-deleted mice resulted in 56% fewer eosinophils in nasal wash fluid after 3 weeks ( Figure 2D ). 
| Eosinophilic inflammation in the upper airways does not protect against influenza virus infection
Wild-type female C57BL/6 mice subjected to repetitive stimulation with A. alternata or diluent control as per Figure 1A were inoculated with Influenza A/HK/1/68 (also in strict intranasal volumes, 2.5 lL/ nare, total 5 lL/mouse) on day 0 as shown in Figure 4A . Mice treated with diluent (pbs) prior to influenza virus (30 TCID 50 units) responded with minimal weight loss only, observed in some mice at days 10 and 14 after inoculation. In contrast, the identical inoculum led to rapid weight loss ( Figure 4B ) and ultimately mortality (Figure 4C ) among mice that had been treated with A. alternata. Interestingly, the presence of eosinophils had no impact on this response.
Eosinophils have been characterized mediators of antiviral host defence in the lower airways, [13] [14] [15] [16] and have characterized activity against the influenza A H1N1 16 and H3N2 in the lower airways (Figure S1 ). However, eosinophil-sufficient wild-type and eosinophil-F I G U R E 2 Eotaxin-1 (CCL-11) promotes eosinophil recruitment to nasal passages. Detection of immunoreactive A, Interleukin-5 (IL-5) B, IL-13 and C, Eotaxin-1 (CCL-11) in nasal wash fluid after 1, 2 and 3 weeks of repetitive challenge with A. alternata as in Figure 1A . D, Eosinophils (percent of total leucocytes) detected in the airways are diminished in eotaxin-1 gene-deleted mice; n = 3-5 mice per time-point, **P < .01, *P < .05; 1-way ANOVA or MannWhitney U-test deficient ΔdblGATA, both subjected to repetitive administration of A. alternata, succumbed to influenza infection by day 11 ( Figure 4D ).
| Heat-inactivation destroys Alternaria alternata protease activity and blunts lethal response to influenza virus
Alternaria alternata elicits inflammation in the lower respiratory tract in part via the actions of its serine proteases, which ultimately result in induction of pro-inflammatory cytokines and leucocyte recruitment; results from cell culture and ex vivo studies suggest that the mechanism may (or may not) involve targeting of protease-activated receptor-2 (PAR2). [36] [37] [38] The A. alternata filtrate in our studies cleaved a fluorescent-tagged casein substrate in a dose-dependent fashion, and that heat-inactivation (95°C for 10 minutes) reduced proteolytic activity to background levels ( Figure 5A ). Eosinophilic inflammation was maintained in response to administration of heatinactivated A. alternata ( Figure 5B ), but the lethal response to influenza virus (150 TCID 50 units in 5 lL) was reduced significantly (Figure 5C ). These results, which suggest that protease activity amplifies pathology in response to influenza infection, are intriguing, given recent findings that, by contrast, implicate PAR2 activation as a protective mechanism in a similar setting 39 ; this is considered further in the Discussion.
| Repetitive stimulation with Alternaria alternata followed by influenza virus infection results in a significant increase in neutrophil recruitment
Wild-type female C57BL/6 mice subjected to repetitive stimulation with A. alternata or diluent control were inoculated with influenza virus on day 0 as in Figure 4A and evaluated on day 6 ( Figure 6A ).
As shown in Figure 6B , influenza virus (150 TCID 50 
| Pretreatment with Alternaria alternata has a minimal impact on virus burden
Despite significant differential survival, titration of virus by qPCR and tissue culture methods showed few to no differences when comparing nasal wash fluids or lung tissue from influenza virusinfected mice that had been treated with A. alternata to those that had been treated with diluent control (Figure 7 ). While higher virus titres were recovered from both A. alternata-and diluent-treated mice that were inoculated with 500 TCID 50 units vs those inoculated with 150 or 30 TCID 50 units, *P < .05, **P < .01 ( Figure 7A, C) , differences between recoveries at a single inoculating dose were nonexistent or minimal (well under 1 log; Figure 7C ) and not reproduced by TCID 50 -analysis ( Figure 7D ).
| Rhinitis followed by virus infection results in an increase in critical pro-inflammatory cytokines
Nasal wash fluids from mice subjected to repetitive administration of A. alternata or diluent control followed by infection with influenza virus (as in Figure 6A ) were evaluated by cytokine profiling. As shown in Figure 8A , nasal wash fluids from A. alternata-treated mice displayed higher levels of nearly all 40 pro-inflammatory mediators evaluated. Among the most prominent are CCL-2 (5.5-fold higher levels in nasal wash fluids from mice subjected to A. alternata vs diluent prior to influenza virus infection), MIP-1a (4.1-fold higher), MIP-1b (3.7-fold higher), IL-6 (3.6-fold higher), MIP-2 (2.2-fold higher) and CXCL-10 (2.3-fold higher). Direct evaluation of nasal wash fluids by ELISA confirmed significant increases in IL-6 (Figure 8B ) and CCL-2 ( Figure 8C ), both cytokines implicated in pathogenic responses in acute influenza infection. 40 
| DISCUSSION
In this study, our primary goal was to examine eosinophil-mediated responses to influenza virus infection in the upper airways. Towards this end, we have adapted a strategy of repetitive dosing with a F I G U R E 4 Eosinophilic inflammation in the upper airways does not protect against influenza virus infection. A, Strategy for influenza virus (Inf A) infection and evaluation. Inf A was administered to mice previously challenged with A. alternata or diluent control (days À19 through days À1) as previously indicated in Figure 1A . B, Weight loss (% original weight determined for each mouse) in response to influenza virus infection. Mice were challenged with A. alternata or diluent control and inoculated on day 0 with 30 TCID 50 units Inf A in 5 lL (2.5 lL per nare) as in Figure 4A ; n = 5 mice per group, **P < .001 at time-points indicated (Student's t test). C, Survival of influenza virus-infected mice (30 TCID 50 units in 5 lL on day 0 as in B.) that had been subjected to repetitive challenge with A. alternata or diluent control; n = 5 mice per group, **P < .005 Log-rank test. D, Survival of wild-type and eosinophil-deficient DdblGATA mice subjected to repetitive challenge with A. alternata or diluent control (pbs) prior to infection with Inf A (500 TCID 50 units in 5 lL); n = 4-5 mice per group, **P < .001 Log-rank test filtrate of the saprophytic fungus, A. alternata, used in earlier studies to elicit allergic lung disease. [41] [42] [43] Here, we show that repetitive stimulation with this filtrate in volumes that are limited to the nasal cavity 19, 22 results in prominent eosinophilic inflammation within the nasal mucosa. Eosinophil recruitment is absent in Rag1 À/À mice, suggesting a critical role for Th2 lymphocytes. 44 Eosinophil recruitment is also associated with cytokines IL-5 and IL-13, and is diminished, but not eliminated, in mice devoid of the chemoattractant, eotaxin-1.
By week 3 of this protocol, profound elevations of nasal wash fluid
IgA were detected in both wild-type and eosinophil-deficient ΔdblGATA mice. This is notable in the light of recent observations that highlight interactions between eosinophils and B cells, including release of crucial eosinophil-derived cytokines that promote survival of antibody-producing cells in the bone marrow and gastrointestinal tract. 45 Our data suggest that eosinophils are dispensable for support of B cells and IgA production in the upper respiratory tract in F I G U R E 5 Heat-inactivation of A. alternata blunts the lethal response to influenza virus. A, Filtrate of A. alternata heated to 95°C for 10 min retains little to no residual protease activity using casein as a substrate; ***P < .001. B, Heat-inactivated filtrate of A. alternata (hi-Aa) administered to upper airways as in Figure 1A promotes eosinophil recruitment to the upper airways as does the active filtrate (Aa), n = 5 mice per group; ns, no significant difference, Mann-Whitney U-test. C, Survival of wild-type mice challenged with A. alternata (Aa), hi-Aa or diluent control as in Figure 4A followed by Inf A (150 TCID 50 units in 5 lL); n = 9-10 mice per group, *P = .05, **P < .005, Log-rank F I G U R E 6 Influenza virus infection of mice challenged with A. alternata results in differential recruitment of pro-inflammatory neutrophils. A.,Strategy for influenza virus (Inf A) infection and evaluation. Influenza virus was administered to mice previously challenged with A. alternata or diluent control as in Figure 4A and evaluated on day 6. B, Neutrophils (% total leucocytes) are more prominent in nasal wash samples from wild-type mice challenged with A. alternata prior to influenza infection (150 TCID 50 units in 5 lL) than those from mice challenged with diluent control; n = 5 mice per group, **P < .01, Mann-Whitney U-test. C, Total neutrophils in nasal wash samples from mice infected with 30 or 150 TCID 50 units influenza A; n = 5 mice per group, **P < .01, Mann-Whitney U-test. D, RNase activity detected in nasal wash fluid in response to influenza infection (500 TCID 50 units); n = 5 mice per group, **P < .01; ***P < .005., 1-way ANOVA, Student's t test | 699 response to repetitive stimulation with A. alternata. These observations may be explained by the fact that IgA production in this setting results from allergic provocation, an activity that might be distinguished from eosinophil-mediated homeostatic support of B-cell function. 3, 45 Before returning to the issue of eosinophils, we were surprised to find that wild-type mice subjected to repetitive stimulation with A. alternata responded to an otherwise survivable inoculum of influenza with significant morbidity and mortality (see Figure 4B , C). This response is blunted in mice subjected to repetitive treatment with heat-inactivated A. alternata (see Figure 5C ), in which fungal proteases have been inactivated ( Figure 5A ). Serine proteases from
A. alternata induce lung inflammation in mice, observations which have been linked to activation of protease-activated receptor-2 (PAR2) on respiratory epithelial cells. 36, 37 In unrelated work, Feld et al 39 have reported that PAR2 activation is a protective mechanism in influenza infection, in studies that focus on infected neutrophils.
Further study of A. alternata, its serine proteases and its interactions with influenza virus infection may provide further insight into this issue.
While virus infection is a critical feature of the morbidity and mortality observed in this study, the enhanced response to influenza virus was not related to a significant increase in virus burden among mice treated with A. alternata. Virus titres were not significantly different from one another when comparing responses from A. alternata-treated vs control diluent-treated mice (see Figure 7 ).
By contrast, virus infection in the A. alternata-treated mice was accompanied by a more prominent local pro-inflammatory response, including up to 30-fold more neutrophils (see Figure 6C) and >100-times more IL-6 (see Figure 8B ). IL-6 is among the proinflammatory cytokines that have been associated with severe disease and poor outcomes in influenza-infected patients, 46, 47 although mouse model studies of acute influenza virus infection do not support a unique focus on IL6 as a negative modulator of disease. 48, 49 These findings are consistent with and extend the current appreciation of host inflammatory responses as providing (A) (B) (C) F I G U R E 8 Eosinophilic inflammation in the nasal passages followed by influenza virus infection results in differential release of critical proinflammatory cytokines. A, Cytokine profiling reveals differential release of numerous pro-inflammatory cytokines in the upper airways, including elevated levels of (a) IL-6, (b) CXCL10, and (c) CCL2, cytokines that have been previously associated with poor outcomes in acute respiratory virus infection (at arrows). Direct evaluation confirmed differential detection of B, IL-6 and C. CCL2 in nasal wash fluid of Aatreated wild-type mice, when compared to diluent-treated, Inf A-infected mice; n = 5 mice per group, **P < .01, *P < .05 major contributions to the outcome of acute respiratory virus infection. 50 Returning the focus to eosinophils in the respiratory tract, we and others have shown previously that eosinophils recruited to the lungs in response to cytokines or allergens reduced the negative sequelae of acute respiratory virus infections in vivo [13] [14] [15] see also Figure S1 ; recently, Samarasinghe et al 16 found that eosinophils isolated from an allergen-sensitized and challenged mouse adoptively transferred into a wild-type mouse had a distinct impact on weight loss secondary to infection with Influenza A H1N1. However, in contrast to what has been observed in the lower airways, activated eosinophils in the nasal passages have no apparent impact on the lethal sequelae of acute influenza virus infection. The mechanisms underlying this distinction remain unclear, and await further characterization of the eosinophils and the inflammatory milieu.
In summary, we report that repetitive intranasal stimulation with a filtrate of A. alternata results in eosinophil recruitment to the nasal mucosa, and, surprisingly, significant morbidity and mortality in response to influenza virus in association with local overproduction of pro-inflammatory cytokines, including IL6. Interestingly, and in contrast to our findings in the lower airways, eosinophils recruited to the nasal passages in response to A. alternata have no measurable impact against lethal respiratory virus infection. To the best of our knowledge, this is the first rhinitis model in which this unique and powerful response to influenza virus has been described. There are several reports that examine susceptibility to influenza A among individuals with allergic rhinitis [51] [52] [53] ; a model such as this might be useful for further exploration of these clinical observations.
